PACIRA BIOSCIENCES INC. - COMMON STOCK

Pacira BioSciences Reports First Quarter 2023 Financial Results

03 May 2023 08:00:01 By Nasdaq GlobeNewswire

Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023

26 Apr 2023 08:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Partners with The Invited Celebrity Classic – a PGA TOUR Champions Event – to Make iovera° The Official Non-Opioid Pain Management Partner

20 Apr 2023 08:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences, Inc. Appoints Christopher Young as Chief Manufacturing Officer

19 Apr 2023 08:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Announces Repayment and Termination of Term Loan B Facility Using Proceeds from New $150 Million 5-Year Term Loan A Facility and Existing Cash Resources

03 Apr 2023 08:00:01 By Nasdaq GlobeNewswire

Pacira Announces FDA Acceptance of sNDA for Exparel Nerve Blocks to Produce Regional Analgesia in Lower Extremity Procedures

29 Mar 2023 08:00:00 By Nasdaq GlobeNewswire

Third Circuit Court Upholds Decision to Dismiss Pacira BioSciences, Inc. Lawsuit

27 Mar 2023 08:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Announces Yvonne Greenstreet to Retire from Board of Directors

22 Mar 2023 08:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences to Participate in Fireside Chat at the 2023 Barclays Global Healthcare Conference

08 Mar 2023 08:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Full-Year and Fourth Quarter 2022 Financial Results

28 Feb 2023 08:00:03 By Nasdaq GlobeNewswire

LPGA, Pacira BioSciences Partner to Raise Awareness of Non-Opioid Pain Management Solutions

23 Feb 2023 08:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Unaudited Total Revenue for 2022 of $666.8 Million

05 Jan 2023 16:30:00 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at the 41st Annual J.P. Morgan Healthcare Conference

04 Jan 2023 08:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $57.5 Million for November 2022

13 Dec 2022 08:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $54.9 Million for October 2022

14 Nov 2022 08:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at Two Healthcare Conferences in November

08 Nov 2022 08:00:03 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Third Quarter 2022 Financial Results

03 Nov 2022 08:00:02 By Nasdaq GlobeNewswire

Pacira to Report Third Quarter 2022 Financial Results on Thursday November 3, 2022

20 Oct 2022 08:00:03 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Third Quarter 2022 Revenue of $167.5 Million

13 Oct 2022 08:00:01 By Nasdaq GlobeNewswire

Sevāredent Sourcing Solutions and Pacira BioSciences Collaborate to Provide Expanded Access to EXPAREL for Patients Undergoing Oral and Maxillofacial Procedures

27 Sep 2022 08:00:00 By Nasdaq GlobeNewswire